Cardiovascular safety of fexofenadine HCl.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  American Journal of Cardiology

• Publication date

  1999-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9149(99)00124-1PMID 10335761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies.

  1998cited by this paper
• Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.

  1997cited by this paper
• AN ANALYSIS OF THE TIME‐RELATIONS OF ELECTROCARDIOGRAMS.

  1997cited by this paper
• Risks of non-sedating antihistamines.

  1997cited by this paper
• Cardiac actions of antihistamines.

  1996cited by this paper
• Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability.

  1996cited by this paper
• Risk of developing life-threatening ventricular arrhythmia associated with tefenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine.

  1994cited by this paper
• Mechanism of the cardiotoxic actions of terfenadine.

  1993cited by this paper
• Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences.

  1993cited by this paper
• Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart.

  1993cited by this paper
• Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin

  1992cited by this paper
• Torsades de Pointes after treatment with terfenadine and ketoconazole.

  1992cited by this paper
• Torsades de pointes occurring in association with terfenadine use.

  1991cited by this paper
• Comparative safety of H1 antihistamines.

  1991cited by this paper
• Comparative safety of H1 antihistamines.

  1991cited by this paper
• Torsades de pointes occurring in association with terfenadine use.

  1990cited by this paper
• Antihistamine- and decongestant-induced performance decrements.

  1990cited by this paper
• Antihistamine therapy in allergic rhinitis.

  1990cited by this paper
• Antihistamine therapy in allergic rhinitis.

  1990cited by this paper
• Allergic rhinitis.

  1988cited by this paper
• Allergic rhinitis. A useful guide to diagnosis and treatment.

  1987cited by this paper

• Twenty-five years: The fexofenadine clinical experience

  2024cites this paper
• Chronic Urticaria in Older Adults: Treatment Considerations

  2023cites this paper
• Effect of Antihistamines (Fexofenadineand Chlopheneramine) on activity some hepatical enzymes by using fertilized hens eggs embryos as a model

  2023cites this paper
• Bradyarrhythmic Cardiac Arrest—A Rare Manifestation of Fexofenadine Cardiotoxicity

  2021cites this paper
• Non‐sedating antihistamines block G‐protein‐gated inwardly rectifying K+ channels

  2019cites this paper
• Comparison of electropharmacological effects between terfenadine and its active derivative fexofenadine using a cross-over study in halothane-anesthetized dogs to analyze variability of pharmacodynamic and pharmacokinetic profiles of terfenadine and torsadogenic risk of fexofenadine.

  2018cites this paper
• Treatment of chronic spontaneous urticaria: Immunomodulatory approaches.

  2017cites this paper
• Updosing of Nonsedating Anti-histamines in Recalcitrant Chronic Urticaria

  2016cites this paper
• Alergiczny nieżyt nosa – nowoczesne leczenie w świetle wytycznych

  2015cites this paper
• Quantitative Estimation of P-glycorptein-Mediated Drug Transport by Mechanistically Modeled Intrinsic Clearance

  2015cites this paper
• Leczenie pokrzywki przewlekłej: zwiększanie dawek leków przeciwhistaminowych – kryteria wyboru terapii

  2014cites this paper
• Use of second generation H1 antihistamines in special situations.

  2013cites this paper
• Second-Generation Antihistamines

  2012cites this paper
• A randomized control trail of stepwise treatment with fluticasone propionate nasal spray and fexofenadine hydrochloride tablet for seasonal allergic rhinitis.

  2012cites this paper
• Chronic Urticaria

  2012cites this paper
• CONSENSUS STATEMENT ON THE MANAGEMENT OF URTICARIA

  2011cites this paper
• A new cytochrome P450 belonging to the 107L subfamily is responsible for the efficient hydroxylation of the drug terfenadine by Streptomyces platensis.

  2011cites this paper
• Evaluation of In Vivo P-Glycoprotein Phenotyping Probes

  2010cites this paper
• QTc interval prolongation by fexofenadine in healthy human volunteers and its correlation with plasma levels of fexofenadine: A demonstration of anticlockwise hysteresis

  2010cites this paper
• Fexofenadine in higher doses in chronic spontaneous urticaria

  2010cites this paper
• Molecular determinants of hERG channel block by terfenadine and cisapride.

  2008cites this paper
• Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies.

  2007cites this paper
• Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis

  2006cites this paper
• Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis.

  2006cites this paper
• Nonsedating antihistamines in the treatment of severe chronic idiopathic urticaria: are they used optimally?

  2006cites this paper
• Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis.

  2006cites this paper
• Fexofenadine Treatment of Atopic Dogs: Preliminary Clinical Results

  2006cites this paper
• Validation of a model for predicting drug-induced torsades de pointes: the risky business of assessing arrhythmogenic potential.

  2006cites this paper
• Stem cells, immortalized cells and primary cells in ADMET assays.

  2006cites this paper
• The life-threatening complications of dermatologic therapies.

  2005cites this paper
• Evaluation of the optimal oral antihistamine for patients with allergic rhinitis.

  2005cites this paper
• CONTRIBUTION OF OATP (ORGANIC ANION-TRANSPORTING POLYPEPTIDE) FAMILY TRANSPORTERS TO THE HEPATIC UPTAKE OF FEXOFENADINE IN HUMANS

  2005cites this paper
• UPTAKE TO THE HEPATIC UPTAKE OF FEXOFENADINE IN HUMANS.

  2005cites this paper
• The efficacy and safety of 30 mg fexofenadine HCl bid in pediatric patients with allergic rhinitis.

  2005cites this paper
• The Assessment of QT/QTc Interval Prolongation in Clinical Trials: A Regulatory Perspective

  2005cites this paper
• Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis – a pooled analysis of three studies

  2004cites this paper
• Effects of Grapefruit Juice and Orange Juice on the Intestinal Efflux of P-Glycoprotein Substrates

  2004cites this paper
• Terfenadine induces thymocyte apoptosis via mitochondrial pathway.

  2004cites this paper
• Metabolites and Bioequivalence

  2004cites this paper
• Markers for Cardiac Repolarization and Risk Assessment

  2003cites this paper
• Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules.

  2003cites this paper
• Efficacy and safety profile of fexofenadine HCl: a unique therapeutic option in H1-receptor antagonist treatment.

  2003cites this paper
• Effects of fexofenadine on the early response to nasal allergen challenge.

  2002cites this paper
• The choice of an H1‐antihistamine for the 21st century

  2002cites this paper
• Review of fexofenadine in the treatment of chronic idiopathic urticaria

  2002cites this paper
• Fexofenadine in Chronic Idiopathic Urticaria: A Clinical and Immunohistochemical Evaluation

  2002cites this paper
• Pharmacological Rescue of Human K+ Channel Long-QT2 Mutations: Human Ether-a-Go-Go-Related Gene Rescue Without Block

  2002cites this paper
• The antihistamine fexofenadine does not affect IKr currents in a case report of drug‐induced cardiac arrhythmia

  2002cites this paper
• Next generation antihistamines: therapeutic rationale, accomplishments and advances

  2002cites this paper
• Comparison of five new antihistamines (H1‐receptor antagonists) in patients with allergic rhinitis using nasal provocation studies and skin tests

  2002cites this paper
• Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997

  2001cites this paper
• Fexofenadine hydrochloride--a new anti-histaminic drug.

  2001cites this paper
• Allergic rhinitis and its impact on asthma.

  2001cites this paper
• Cardiotoxicity of new antihistamines and cisapride.

  2001cites this paper
• Antihistamines.

  2001cites this paper
• Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus

  2001cites this paper
• Safety of fexofenadine in children treated for seasonal allergic rhinitis.

  2001cites this paper
• Fexofenadine

  2000cites this paper
• QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

  2000cites this paper
• The potential of active metabolites of antihistamines in the management of allergic disease

  2000cites this paper
• High-throughput approaches to the quantitative analysis of ketoconazole, a potent inhibitor of cytochrome P450 3A4, in human plasma.

  2000cites this paper
• The metabolic profile of second‐generation antihistamines

  2000cites this paper
• Fexofenadine‐induced QT prolongation: a myth or fact?

  2000cites this paper
• Paediatric issues relating to the pharmacotherapy of allergic rhinitis

  2000cites this paper
• Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis

  2000cites this paper
• Safety of second generation antihistamines.

  2000cites this paper
• A non-comparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis.

  2000cites this paper
• Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.

  2000cites this paper
• QT lengthening and life-threatening arrhythmias associated with fexofenadine.

  2000cites this paper
• Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias

  2000cites this paper
• Effects of Fexofenadine Hydrochloride on Psychomotor Performance

  2000cites this paper
• Clinical Pharmacology Study of Drug Interaction between Fexofenadine Hydrochloride and Erythromycin

  2000cites this paper
• Hepatic Disposition of Fexofenadine: Influence of the Transport Inhibitors Erythromycin and Dibromosulphothalein

  2000cites this paper
• Prolonged QTc time and ventricular arrhythmia with fexofenadine.

  1999cites this paper
• A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.

  1999cites this paper
• Clinical Pharmacology of New Histamine H1 Receptor Antagonists

  1999cites this paper